Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit K pseudogene 3 (EIF3KP3) is a processed pseudogene in the human genome, thought to be derived from the functional EIF3K gene by retrotransposition[1]. Pseudogenes like EIF3KP3 usually lack protein-coding capacity and are not involved directly in cellular biochemical pathways. There is no evidence that EIF3KP3 plays a role in translation initiation, cellular signaling, disease, or as a drug target. While some pseudogenes have regulatory functions or have been linked to disease, no such role has been documented for EIF3KP3 to date[1][3]. EIF3KP3 is a pseudogene with no known function or direct implication as a disease gene or therapeutic target. It should not be confused with the functional EIF3K subunit, which is part of the multi-protein eIF3 complex involved in translation initiation[1][2][4][5]. The designation "receptor" or "target" does not apply in this case, and its use as a molecular target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit K pseudogene 3 (EIF3KP3).